A detailed history of Skandinaviska Enskilda Banken Ab (Publ) transactions in Catalent, Inc. stock. As of the latest transaction made, Skandinaviska Enskilda Banken Ab (Publ) holds 49,495 shares of CTLT stock, worth $3.02 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
49,495
Previous 34,495 43.48%
Holding current value
$3.02 Million
Previous $1.94 Million 54.56%
% of portfolio
0.01%
Previous 0.01%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$56.16 - $60.96 $842,400 - $914,400
15,000 Added 43.48%
49,495 $3 Million
Q2 2024

Aug 13, 2024

SELL
$53.58 - $57.02 $6.69 Million - $7.12 Million
-124,944 Reduced 78.36%
34,495 $1.94 Million
Q1 2024

May 13, 2024

SELL
$42.56 - $59.82 $2.66 Million - $3.74 Million
-62,539 Reduced 28.17%
159,439 $9 Million
Q4 2023

Feb 14, 2024

SELL
$32.18 - $46.57 $95,188 - $137,754
-2,958 Reduced 1.32%
221,978 $9.97 Million
Q3 2023

Nov 09, 2023

SELL
$44.2 - $50.2 $2,652 - $3,012
-60 Reduced 0.03%
224,936 $10.2 Million
Q2 2023

Aug 07, 2023

BUY
$31.86 - $67.26 $22,684 - $47,889
712 Added 0.32%
224,996 $9.76 Million
Q1 2023

May 11, 2023

SELL
$45.44 - $74.26 $49,029 - $80,126
-1,079 Reduced 0.48%
224,284 $14.7 Million
Q4 2022

Feb 08, 2023

SELL
$41.39 - $81.0 $7,905 - $15,471
-191 Reduced 0.08%
225,363 $10.1 Million
Q3 2022

Nov 14, 2022

SELL
$72.36 - $113.1 $509,559 - $796,450
-7,042 Reduced 3.03%
225,554 $16.3 Million
Q2 2022

Aug 10, 2022

SELL
$87.2 - $114.05 $181,550 - $237,452
-2,082 Reduced 0.89%
232,596 $25 Million
Q1 2022

May 11, 2022

SELL
$94.19 - $124.49 $401,061 - $530,078
-4,258 Reduced 1.78%
234,678 $26 Million
Q4 2021

Feb 10, 2022

BUY
$119.57 - $139.07 $34,077 - $39,634
285 Added 0.12%
238,936 $30.7 Million
Q3 2021

Nov 10, 2021

BUY
$109.17 - $142.35 $21.2 Million - $27.6 Million
194,115 Added 435.86%
238,651 $31.8 Million
Q2 2021

Aug 10, 2021

BUY
$100.34 - $115.69 $95,222 - $109,789
949 Added 2.18%
44,536 $4.82 Million
Q1 2021

May 14, 2021

BUY
$101.51 - $125.27 $343,408 - $423,788
3,383 Added 8.41%
43,587 $4.59 Million
Q4 2020

Feb 11, 2021

SELL
$85.88 - $105.36 $80,555 - $98,827
-938 Reduced 2.28%
40,204 $4.18 Million
Q3 2020

Nov 12, 2020

BUY
$72.74 - $92.5 $1.2 Million - $1.53 Million
16,503 Added 66.98%
41,142 $3.52 Million
Q2 2020

Aug 13, 2020

BUY
$48.02 - $79.04 $1.18 Million - $1.95 Million
24,639 New
24,639 $1.81 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Skandinaviska Enskilda Banken Ab (Publ) Portfolio

Follow Skandinaviska Enskilda Banken Ab (Publ) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Skandinaviska Enskilda Banken Ab (Publ), based on Form 13F filings with the SEC.

News

Stay updated on Skandinaviska Enskilda Banken Ab (Publ) with notifications on news.